RecruitingPhase 4

Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy

Sweden100 participantsStarted 2019-09-10

Plain-language summary

Betamethasone is currently given routinely in conjunction with tonsillectomy surgery at the majority of Ear, Nose \& Throat clinics in Sweden. The scientific evidence regarding the effects of betamethasone in adults is limited when it comes to postoperative nausea (PONV), pain and postoperative bleeding.

Who can participate

Age range12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Signed informed consent Age over 12 years Planned for elective bilateral tonsillectomy Exclusion Criteria: * • Insulin dependent diabetes mellitus * NSAID or corticosteroid intolerance * Pregnancy * Gastric ulcer * Immunodeficiency * Treatment for chronic pain * Psychiatric disorders

What they're measuring

Postoperative nausea and vomiting

Timeframe: 0-5 days postop

Trial details

NCT IDNCT03783182

SponsorUmeå University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-20

Contact for this trial

Krister Tano, MD, PhD

0046705569043 krister.tano@umu.se

View on ClinicalTrials.gov More Tonsillectomy trials